Vet Pharma Friesoythe GmbH

Form 483 issued March 24, 2023 · Friesoythe, Germany

Inspection
Mar 16 – Mar 24, 2023
Investigator
Justin A. Boyd
Observations
9
Pages
14
FEI number
3002808866

In short: On March 24, 2023, FDA issued a Form 483 with 9 observations to Vet Pharma Friesoythe GmbH in Friesoythe, Germany (FEI 3002808866) after an inspection that ran Mar 16 – Mar 24, 2023. The investigator was Justin A. Boyd. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Observations span 4 systems, led by facilities & equipment.

Facilities & equipment3
Production2
Quality system1
Laboratory controls1
Other2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products…

  2. 02

    Observation 2: scanned text, readable in the full document.

  3. 03

    (b) (4) processing areas are deficient regarding the system for cleaning and disinfecting the room and…

  4. 04

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Vet Pharma Friesoythe GmbH?

FDA listed 9 observations on this Form 483, mostly about facilities & equipment, production and quality system. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Vet Pharma Friesoythe GmbH?

Justin A. Boyd is named on this Form 483, for the inspection of Mar 16 – Mar 24, 2023. Each investigator has a profile showing what they cite most.

When was Vet Pharma Friesoythe GmbH inspected by FDA?

The inspection ran Mar 16 – Mar 24, 2023, and the Form 483 is dated March 24, 2023.

How do I get the full Form 483 for Vet Pharma Friesoythe GmbH?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free